GGrantIndex
Sort

64,565 grants matching drug discovery

Maternal mediators of fetal growth restriction linked to prenatal alcohol exposure

$629,538
Christina Chambers · University Of California, San Diego · R01 · FY2025 · AA

Phenotypic marker-guided development of selective antimetastasis therapeutic leads

$629,518
Sui Huang · Northwestern University At Chicago · R01 · FY2023 · CA

Targeting Nuclear HSF1 as a Novel Anti-HCMV Strategy

$629,516
Gary Ching Tao Chan · Upstate Medical University · R01 · FY2025 · AI

Synthesis of Anti-Infective Agents

$629,515
K. C. Nicolaou · Scripps Research Institute, The · R01 · FY2012 · AI

Functional maturation of amygdala circuitry during adolescence

$629,510
Joshua G Corbin · Children'S Research Institute · R56 · FY2024 · MH

Heartland Institute for Clinical and Translational Research

$629,476
Richard J. Barohn · University Of Kansas Medical Center · KL2 · FY2012 · TR

Immunoproteasome inhibitors for the treatment of Alzheimer’s disease

$629,282
Kyung Bo Kim · University Of Kentucky · R01 · FY2021 · AG

Structural Basis of Signal Instigation Through Metabotropic Glutamate Receptors

$629,267
Georgios Skiniotis · University Of Michigan At Ann Arbor · R01 · FY2015 · NS

Multi-tissue high-throughput proteomic and genomic study in Parkinson's Disease

$629,218
Bruno A. Benitez · Washington University · R01 · FY2020 · NS

Research and Development of Effective Therapies for Patients with Rare Tumors

$629,166
Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2020 · CA

Plasmodium Genome Database

$629,123
University Of Pennsylvania · R01 · FY2004 · AI

Mechanisms of Endogenous DNA Damage Promotion

$629,046
Susan M. Rosenberg · Baylor College Of Medicine · R01 · FY2024 · CA

Administrative Core

$629,039
Michael J Bertram · University Of Alabama At Birmingham · P30 · FY2017 · CA

Understanding interactions between brain reward and sleep systems in driving maladaptive behaviors

$629,003
Andrew Kesner · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2025 · AA

The Conundrum of Absentee Receptors: Efficacy Potentiation Through Drug-Receptor Modulation

$628,970
Mark W Grinstaff · Boston University (Charles River Campus) · R01 · FY2024 · AR

NEUROPROTECTION--INHIBITION OF OXIDATIVE STRESS

$628,942
Children'S Memorial Hospital (Chicago) · P01 · FY2000 · MH

Developmental Funds Core

$628,824
Andrew K Godwin · University Of Kansas Medical Center · P30 · FY2025 · CA

Knee OA: Setting Priorities for Care, Policy, Research

$628,748
Elena Losina · Brigham And Women'S Hospital · R01 · FY2008 · AR

Reversible Covalent BTK Degraders as the Next Generation Targeted Therapy to Treat B-cell Malignancies

$628,719
Jin Wang · Baylor College Of Medicine · R01 · FY2022 · CA

Reversible Covalent BTK Degraders as the Next Generation Targeted Therapy to Treat B-cell Malignancies

$628,719
Jin Wang · Baylor College Of Medicine · R01 · FY2023 · CA

Graduate Training in Cellular and Molecular Pharmacology

$628,649
Joan Heller Brown · University Of California, San Diego · T32 · FY2018 · GM

Uncovering the molecular and cellular mechanisms underlying AD using CRISPR/Cas9-edited isogenic neural cells

$628,647
Yanhong Shi · Beckman Research Institute/City Of Hope · R56 · FY2019 · AG

EXPRESSION OF GPCRS FOR STRUCTURE DETERMINATION

$628,625
Three-Dimensional Pharmaceuticals, Inc. · R44 · FY2001 · GM

Mapping Protein Interaction Networks Essential for Gonococcal Pathogenesis

$628,605
Andrew Emili · Boston University Medical Campus · R01 · FY2022 · AI

Discovery Proteomics Core

$628,548
Tukiet T Lam · Yale University · P30 · FY2017 · DA